Cargando…
Antibacterial and Sterilizing Effect of Benzylpenicillin in Tuberculosis
The modern chemotherapy era started with Fleming's discovery of benzylpenicillin. He demonstrated that benzylpenicillin did not kill Mycobacterium tuberculosis. In this study, we found that >64 mg/liter of static benzylpenicillin concentrations killed 1.16 to 1.43 log(10) CFU/ml below starti...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5786797/ https://www.ncbi.nlm.nih.gov/pubmed/29180526 http://dx.doi.org/10.1128/AAC.02232-17 |
_version_ | 1783295828888125440 |
---|---|
author | Deshpande, Devyani Srivastava, Shashikant Bendet, Paula Martin, Katherine R. Cirrincione, Kayle N. Lee, Pooi S. Pasipanodya, Jotam G. Dheda, Keertan Gumbo, Tawanda |
author_facet | Deshpande, Devyani Srivastava, Shashikant Bendet, Paula Martin, Katherine R. Cirrincione, Kayle N. Lee, Pooi S. Pasipanodya, Jotam G. Dheda, Keertan Gumbo, Tawanda |
author_sort | Deshpande, Devyani |
collection | PubMed |
description | The modern chemotherapy era started with Fleming's discovery of benzylpenicillin. He demonstrated that benzylpenicillin did not kill Mycobacterium tuberculosis. In this study, we found that >64 mg/liter of static benzylpenicillin concentrations killed 1.16 to 1.43 log(10) CFU/ml below starting inoculum of extracellular and intracellular M. tuberculosis over 7 days. When we added the β-lactamase inhibitor avibactam, benzylpenicillin maximal kill (E(max)) of extracellular log-phase-growth M. tuberculosis was 6.80 ± 0.45 log(10) CFU/ml at a 50% effective concentration (EC(50)) of 15.11 ± 2.31 mg/liter, while for intracellular M. tuberculosis it was 2.42 ± 0.14 log(10) CFU/ml at an EC(50) of 6.70 ± 0.56 mg/liter. The median penicillin (plus avibactam) MIC against South African clinical M. tuberculosis strains (80% either multidrug or extensively drug resistant) was 2 mg/liter. We mimicked human-like benzylpenicillin and avibactam concentration-time profiles in the hollow-fiber model of tuberculosis (HFS-TB). The percent time above the MIC was linked to effect, with an optimal exposure of ≥65%. At optimal exposure in the HFS-TB, the bactericidal activity in log-phase-growth M. tuberculosis was 1.44 log(10) CFU/ml/day, while 3.28 log(10) CFU/ml of intracellular M. tuberculosis was killed over 3 weeks. In an 8-week HFS-TB study of nonreplicating persistent M. tuberculosis, penicillin-avibactam alone and the drug combination of isoniazid, rifampin, and pyrazinamide both killed >7.0 log(10) CFU/ml. Monte Carlo simulations of 10,000 preterm infants with disseminated disease identified an optimal dose of 10,000 U/kg (of body weight)/h, while for pregnant women or nonpregnant adults with pulmonary tuberculosis the optimal dose was 25,000 U/kg/h, by continuous intravenous infusion. Penicillin-avibactam should be examined for effect in pregnant women and infants with drug-resistant tuberculosis, to replace injectable ototoxic and teratogenic second-line drugs. |
format | Online Article Text |
id | pubmed-5786797 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | American Society for Microbiology |
record_format | MEDLINE/PubMed |
spelling | pubmed-57867972018-02-07 Antibacterial and Sterilizing Effect of Benzylpenicillin in Tuberculosis Deshpande, Devyani Srivastava, Shashikant Bendet, Paula Martin, Katherine R. Cirrincione, Kayle N. Lee, Pooi S. Pasipanodya, Jotam G. Dheda, Keertan Gumbo, Tawanda Antimicrob Agents Chemother Experimental Therapeutics The modern chemotherapy era started with Fleming's discovery of benzylpenicillin. He demonstrated that benzylpenicillin did not kill Mycobacterium tuberculosis. In this study, we found that >64 mg/liter of static benzylpenicillin concentrations killed 1.16 to 1.43 log(10) CFU/ml below starting inoculum of extracellular and intracellular M. tuberculosis over 7 days. When we added the β-lactamase inhibitor avibactam, benzylpenicillin maximal kill (E(max)) of extracellular log-phase-growth M. tuberculosis was 6.80 ± 0.45 log(10) CFU/ml at a 50% effective concentration (EC(50)) of 15.11 ± 2.31 mg/liter, while for intracellular M. tuberculosis it was 2.42 ± 0.14 log(10) CFU/ml at an EC(50) of 6.70 ± 0.56 mg/liter. The median penicillin (plus avibactam) MIC against South African clinical M. tuberculosis strains (80% either multidrug or extensively drug resistant) was 2 mg/liter. We mimicked human-like benzylpenicillin and avibactam concentration-time profiles in the hollow-fiber model of tuberculosis (HFS-TB). The percent time above the MIC was linked to effect, with an optimal exposure of ≥65%. At optimal exposure in the HFS-TB, the bactericidal activity in log-phase-growth M. tuberculosis was 1.44 log(10) CFU/ml/day, while 3.28 log(10) CFU/ml of intracellular M. tuberculosis was killed over 3 weeks. In an 8-week HFS-TB study of nonreplicating persistent M. tuberculosis, penicillin-avibactam alone and the drug combination of isoniazid, rifampin, and pyrazinamide both killed >7.0 log(10) CFU/ml. Monte Carlo simulations of 10,000 preterm infants with disseminated disease identified an optimal dose of 10,000 U/kg (of body weight)/h, while for pregnant women or nonpregnant adults with pulmonary tuberculosis the optimal dose was 25,000 U/kg/h, by continuous intravenous infusion. Penicillin-avibactam should be examined for effect in pregnant women and infants with drug-resistant tuberculosis, to replace injectable ototoxic and teratogenic second-line drugs. American Society for Microbiology 2018-01-25 /pmc/articles/PMC5786797/ /pubmed/29180526 http://dx.doi.org/10.1128/AAC.02232-17 Text en Copyright © 2018 Deshpande et al. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Experimental Therapeutics Deshpande, Devyani Srivastava, Shashikant Bendet, Paula Martin, Katherine R. Cirrincione, Kayle N. Lee, Pooi S. Pasipanodya, Jotam G. Dheda, Keertan Gumbo, Tawanda Antibacterial and Sterilizing Effect of Benzylpenicillin in Tuberculosis |
title | Antibacterial and Sterilizing Effect of Benzylpenicillin in Tuberculosis |
title_full | Antibacterial and Sterilizing Effect of Benzylpenicillin in Tuberculosis |
title_fullStr | Antibacterial and Sterilizing Effect of Benzylpenicillin in Tuberculosis |
title_full_unstemmed | Antibacterial and Sterilizing Effect of Benzylpenicillin in Tuberculosis |
title_short | Antibacterial and Sterilizing Effect of Benzylpenicillin in Tuberculosis |
title_sort | antibacterial and sterilizing effect of benzylpenicillin in tuberculosis |
topic | Experimental Therapeutics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5786797/ https://www.ncbi.nlm.nih.gov/pubmed/29180526 http://dx.doi.org/10.1128/AAC.02232-17 |
work_keys_str_mv | AT deshpandedevyani antibacterialandsterilizingeffectofbenzylpenicillinintuberculosis AT srivastavashashikant antibacterialandsterilizingeffectofbenzylpenicillinintuberculosis AT bendetpaula antibacterialandsterilizingeffectofbenzylpenicillinintuberculosis AT martinkatheriner antibacterialandsterilizingeffectofbenzylpenicillinintuberculosis AT cirrincionekaylen antibacterialandsterilizingeffectofbenzylpenicillinintuberculosis AT leepoois antibacterialandsterilizingeffectofbenzylpenicillinintuberculosis AT pasipanodyajotamg antibacterialandsterilizingeffectofbenzylpenicillinintuberculosis AT dhedakeertan antibacterialandsterilizingeffectofbenzylpenicillinintuberculosis AT gumbotawanda antibacterialandsterilizingeffectofbenzylpenicillinintuberculosis |